Danaher Co. (DHR) Position Decreased by Pitcairn Co.
Pitcairn Co. decreased its stake in Danaher Co. (NYSE:DHR) by 5.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 40,271 shares of the conglomerate’s stock after selling 2,271 shares during the period. Danaher accounts for 0.4% of Pitcairn Co.’s holdings, making the stock its 29th biggest position. Pitcairn Co.’s holdings in Danaher were worth $3,738,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently added to or reduced their stakes in the stock. BlackRock Inc. lifted its stake in Danaher by 4.6% in the 4th quarter. BlackRock Inc. now owns 40,984,366 shares of the conglomerate’s stock worth $3,804,169,000 after acquiring an additional 1,789,474 shares in the last quarter. Parnassus Investments CA lifted its stake in Danaher by 0.3% in the 3rd quarter. Parnassus Investments CA now owns 9,796,584 shares of the conglomerate’s stock worth $840,351,000 after acquiring an additional 29,381 shares in the last quarter. Flossbach Von Storch AG lifted its stake in Danaher by 17.2% in the 3rd quarter. Flossbach Von Storch AG now owns 6,776,921 shares of the conglomerate’s stock worth $581,324,000 after acquiring an additional 994,902 shares in the last quarter. Geode Capital Management LLC lifted its stake in Danaher by 2.7% in the 4th quarter. Geode Capital Management LLC now owns 6,263,971 shares of the conglomerate’s stock worth $580,150,000 after acquiring an additional 167,442 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Danaher by 1.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 4,630,035 shares of the conglomerate’s stock worth $397,144,000 after acquiring an additional 63,327 shares in the last quarter. Institutional investors and hedge funds own 76.83% of the company’s stock.
Danaher Co. (DHR) opened at $96.22 on Monday. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39. Danaher Co. has a one year low of $78.97 and a one year high of $104.82. The firm has a market capitalization of $67,120.13, a P/E ratio of 23.88, a P/E/G ratio of 2.03 and a beta of 1.03.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, March 29th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.67%. This is an increase from Danaher’s previous quarterly dividend of $0.14. The ex-dividend date is Wednesday, March 28th. Danaher’s dividend payout ratio (DPR) is presently 15.86%.
In related news, CFO Daniel L. Comas sold 62,989 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $101.96, for a total value of $6,422,358.44. Following the transaction, the chief financial officer now directly owns 227,805 shares of the company’s stock, valued at approximately $23,226,997.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP William K. Daniel sold 131,066 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $102.05, for a total value of $13,375,285.30. Following the completion of the transaction, the executive vice president now directly owns 270,523 shares in the company, valued at $27,606,872.15. The disclosure for this sale can be found here. Insiders sold a total of 313,260 shares of company stock worth $31,657,786 over the last three months. 12.20% of the stock is owned by company insiders.
Several equities research analysts recently issued reports on the company. Credit Suisse Group increased their price objective on Danaher from $99.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. Stifel Nicolaus increased their price objective on Danaher from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Wednesday, January 31st. Zacks Investment Research downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Robert W. Baird reaffirmed a “buy” rating on shares of Danaher in a research note on Friday, January 12th. Finally, UBS Group started coverage on Danaher in a research note on Monday, January 22nd. They set a “buy” rating and a $99.97 price target for the company. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. Danaher presently has an average rating of “Buy” and a consensus price target of $101.23.
COPYRIGHT VIOLATION NOTICE: “Danaher Co. (DHR) Position Decreased by Pitcairn Co.” was first published by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/danaher-co-dhr-position-decreased-by-pitcairn-co/1909621.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.